Dr. Thampi John, MD

Dr. John practices at Call Group of Srivatsa in Fresno, California.

Dr. John's NPI, 1043244122, was assigned on July 11, 2006. Dr. John graduated from Patliputra Med Coll in 1983. Dr. John holds California license A52031.

Dr. John's primary practice is Call Group of Srivatsa, at 30 E River Park Pl W, Fresno, CA 93720-1545. The practice phone is (559) 434-6232.

Dr. John's primary practice is Call Group of Srivatsa in Fresno, California. Dr. John is also affiliated with Community Regional Medical Center. The medical group on file is The Permanente Medical Group, Inc. Dmand AI also links Dr. John to 3 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. John practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. John's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. John's licenses on file in 2 states: California and New Jersey.

Dmand AI lists angioplasty, atrial fibrillation and flutter, cardiac arrhythmia, cardiac catheterization, cardiomyopathy, chronic hypertension, coronary artery disease and heart blockage among the conditions Dr. John treats.

CMS data shows 2,821 Medicare services from Dr. John across 29 procedure codes in 2024, for 765 Medicare patients. Medicare paid $342,979 for them.

CMS counts 765 Medicare patients who saw Dr. John in 2024. The largest group is 65 to 74, with 307 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. John's median patient age at 71, with 45% women.

In 2024, Dr. John wrote 2,602 Medicare Part D claims for 465 patients. 79% of them were for generic drugs. CMS names the drug for 2,396 of them, across 36 drugs with 11 or more claims each, at $525,734 in total drug cost. In 2023, CMS named 2,416 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. John for performance year 2024, reported individually. Dr. John accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 103 procedures of pacemaker insertion or repair by Dr. John, more than 98% of the clinicians it reports for that procedure.

Dmand AI links Dr. John to 1 clinical trial. Conditions studied include Heart Failure and Heart Diseases.

CMS Open Payments shows 830 general payments to Dr. John from 46 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Boston Scientific Corporation paid the most, $12,769.

Dr. John graduated from Patliputra Med Coll in 1983.

Dr. John is in network with 14 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 8. Check the plan with the practice before a visit.